News
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score can help to guide treatment decisions in patients living with ...
Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.
Andrew Evens, DO, MBA, MSc, discusses a modern way of stratifying risk in patients with early-stage Hodgkin lymphoma.
Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care ...
Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...
TP53 mutation is a critical predictor of early disease progression and poor prognosis in mantle cell lymphoma (MCL). Optimal treatment for these patients remains unclear. This systematic review and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results